A BILL 
To amend title XVIII of the Social Security Act to require 
manufacturers of certain single-dose vial drugs payable 
under part B of the Medicare program to provide rebates 
with respect to amounts of such drugs discarded, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Recovering Excessive 
4
Funds for Unused and Needless Drugs Act of 2019’’ or 
5
the ‘‘REFUND Act of 2019’’. 
6
03:40 Aug 16, 2019
H4178
2 
•HR 4178 IH
SEC. 2. REQUIRING MANUFACTURERS OF CERTAIN SINGLE- 
1
DOSE VIAL DRUGS PAYABLE UNDER PART B 
2
OF THE MEDICARE PROGRAM TO PROVIDE 
3
REBATES WITH RESPECT TO DISCARDED 
4
AMOUNTS OF SUCH DRUGS. 
5
(a) IN GENERAL.—Section 1834 of the Social Secu-
6
rity Act (42 U.S.C. 1395m) is amended by adding at the 
7
end the following new subsection: 
8
‘‘(x) REBATE
FOR CERTAIN DISCARDED SINGLE- 
9
DOSE VIAL DRUGS.— 
10
‘‘(1) IN GENERAL.—The manufacturer (as de-
11
fined in section 1847A(c)(6)(A)) of a rebatable sin-
12
gle-dose vial drug furnished in a calendar quarter 
13
shall, not later than 30 days after the date of receipt 
14
of information described in paragraph (2)(A)(iii) 
15
with respect to such quarter, provide to the Sec-
16
retary a rebate that is equal to the amount specified 
17
in paragraph (3) for such drug for such quarter. 
18
‘‘(2) SECRETARIAL DUTIES.— 
19
‘‘(A) IN
GENERAL.—For each calendar 
20
quarter, the Secretary shall, with respect to a 
21
rebatable single-dose vial drug of a manufac-
22
turer furnished during such quarter— 
23
‘‘(i) require, through use of a modifier 
24
such as the JW modifier used as of the 
25
date of enactment of this subsection (or 
26
03:40 Aug 16, 2019
H4178
3 
•HR 4178 IH
any such successor code that includes such 
1
data as determined appropriate by the Sec-
2
retary), an indication on a claim for such 
3
drug of the amount of such drug that was 
4
discarded after such drug was furnished, if 
5
any; 
6
‘‘(ii) determine the rebatable amount 
7
(as defined in subparagraph (B)) with re-
8
spect to such drug; and 
9
‘‘(iii) not later than 60 days after the 
10
end of such quarter, provide to such manu-
11
facturer notice of— 
12
‘‘(I) the total number of units of 
13
such drug discarded during such 
14
quarter (as determined by the Sec-
15
retary based on the aggregate rebata-
16
ble amount (as so defined) with re-
17
spect to such drug for such quarter), 
18
if any; and 
19
‘‘(II) the rebate amount specified 
20
in paragraph (3) for such drug and 
21
such quarter. 
22
‘‘(B) REBATABLE
AMOUNT.—The term 
23
‘rebatable amount’ means, with respect to a 
24
rebatable single-dose vial drug of a manufac-
25
03:40 Aug 16, 2019
H4178
4 
•HR 4178 IH
turer furnished during a quarter, 90 percent of 
1
the amount (if any) of such drug that was dis-
2
carded as indicated pursuant to subparagraph 
3
(A)(i). 
4
‘‘(3) REBATE AMOUNT.—The amount of the re-
5
bate specified in this paragraph is, with respect to 
6
a rebatable single-dose vial drug of a manufacturer 
7
furnished in a calendar quarter, an amount equal to 
8
the product of— 
9
‘‘(A) the total number of units of such 
10
drug discarded during such quarter as deter-
11
mined under paragraph (2)(A)(iii)(I); and 
12
‘‘(B) the lesser of— 
13
‘‘(i) the average sales price (as de-
14
fined in section 1847A(c)(1)) for a unit of 
15
such drug for such quarter (or, in the case 
16
of a drug subject to an agreement with 
17
such manufacturer under section 340B of 
18
the Public Health Service Act, the price 
19
for a unit of such drug for such quarter 
20
under such agreement); or 
21
‘‘(ii) the wholesale acquisition cost (as 
22
defined in section 1847A(c)(6)(B)) for a 
23
unit of such drug. 
24
03:40 Aug 16, 2019
H4178
5 
•HR 4178 IH
‘‘(4) REBATE DEPOSITS.—Amounts paid as re-
1
bates pursuant to paragraph (1) shall be deposited 
2
into the Federal Supplementary Medical Insurance 
3
Trust Fund established under section 1841. 
4
‘‘(5) ENFORCEMENT.— 
5
‘‘(A) AUDITS.—Each manufacturer of a 
6
rebatable single dose-vial drug that is required 
7
to provide a rebate under this subsection shall 
8
be subject to periodic audit with respect to such 
9
drug and such rebates by the Secretary. 
10
‘‘(B) CIVIL MONEY PENALTY.— 
11
‘‘(i) IN
GENERAL.—The Secretary 
12
shall impose a civil money penalty on a 
13
manufacturer of a rebatable single dose- 
14
vial drug who has failed to comply with the 
15
requirement under paragraph (1) for such 
16
drug for a calendar quarter in an amount 
17
the Secretary determines is commensurate 
18
with the sum of— 
19
‘‘(I) the amount that the manu-
20
facturer would have paid under such 
21
paragraph with respect to such drug 
22
for such quarter; and 
23
‘‘(II) 25 percent of such amount. 
24
03:40 Aug 16, 2019
H4178
6 
•HR 4178 IH
‘‘(ii) APPLICATION.—The provisions 
1
of section 1128A (other than subsections 
2
(a) and (b)) shall apply to a civil money 
3
penalty under this subparagraph in the 
4
same manner as such provisions apply to a 
5
penalty 
or 
proceeding 
under 
section 
6
1128A(a). 
7
‘‘(6) DEFINITIONS.—In this subsection: 
8
‘‘(A) 
REBATABLE
SINGLE-DOSE
VIAL 
9
DRUG.—The term ‘rebatable single-dose vial 
10
drug’ means a single source drug or biological 
11
(as defined in section 1847A(c)(6)(D)) paid for 
12
under this part and furnished on or after Janu-
13
ary 1, 2020, from a single-dose vial. 
14
‘‘(B) UNIT.—The term ‘unit’ has the 
15
meaning 
given 
such 
term 
in 
section 
16
1847A(b)(2)(B).’’. 
17
(b) COLLECTION OF COINSURANCE ONLY FOR POR-
18
TION OF REBATABLE SINGLE-DOSE VIAL DRUG ADMINIS-
19
TERED.—Section 1833 of the Social Security Act (42 
20
U.S.C. 1395l) is amended— 
21
(1) in subsection (a)(1)(S), by inserting ‘‘sub-
22
ject to subsection (cc),’’ before ‘‘with respect to’’; 
23
and 
24
03:40 Aug 16, 2019
H4178
7 
•HR 4178 IH
(2) by adding at the end the following new sub-
1
section: 
2
‘‘(cc) COLLECTION
OF COINSURANCE ONLY
FOR 
3
4
MINISTERED.—When processing a claim for a rebatable 
5
single-dose vial drug (as defined in section 1834(w)(6)), 
6
the Secretary, acting through the relevant Medicare ad-
7
ministrative contractor with respect to such claim, shall 
8
only collect coinsurance from a beneficiary, taking into ac-
9
count any coverage under a Medicare supplemental policy 
10
certified under section 1882 or any other supplemental in-
11
surance coverage of the beneficiary, with respect to the 
12
portion of the drug administered (as indicated by the J- 
13
portion of the claim for the drug used as of the date of 
14
enactment of this subsection, or any successor code that 
15
includes such data as determined appropriate by the Sec-
16
retary), in an amount equal to 20 percent of the amount 
17
of payment that would be made if payment for the claim 
18
was based only on the portion of the drug administered 
19
(as so indicated). Nothing in the preceding sentence shall 
20
affect the amount paid to the provider of services or sup-
21
plier with respect to the drug under this part (as deter-
22
mined based on the total amount of the drug for which 
23
the claim was submitted, including the portion of the drug 
24
administered and the portion discarded, as indicated by 
25
03:40 Aug 16, 2019
H4178
8 
•HR 4178 IH
the J-portion of the claim and the JW modifier, respec-
1
tively, used as of such date of enactment or any successor 
2
codes that include such data as determined appropriate 
3
by the Secretary).’’. 
4
Æ 
03:40 Aug 16, 2019
H4178
